ASCRS 2024: 10-year results from a real-world study shed new light on glaucoma

News
Video

At ASCRS in Boston, Paul Harasymowycz, MD shared a decade's worth of data on MIGS procedures for primary open-angle glaucoma

At this year's ASCRS meeting in Boston, Massachusetts, we caught up with Paul Harasymowycz, MD, who detailed his presentation "Decade-Long Outcomes of Two First-Generation Trabecular Micro-Bypass Stents with Cataract Surgery in Primary Open-Angle Glaucoma." Here, he shares the highlights from a decade's worth of data.

Editor's note: The below transcript has been lightly edited for clarity.

Hello, I'm Dr Paul Harasymowycz, from University of Montreal and McGill University. Today we have the pleasure of presenting our 10-year results of using two [first-generation trabecular micro bypass] iStents with cataract surgery. So that's a decade of results using MIGS surgery. I think that's a very important contribution to our knowledge.

This was a real world study. In the end, we had 56 patients that we followed over time. The most important is that they had OCT stability up until 10 years. The average pressure before was higher than 18. And even after 10 years, a decade, their pressure was almost at 14. That's very important. Another finding in our study was that 75% of our patients, their pressure was below 15. And we know, usually, the lower we keep the pressure, the less likelihood is that their glaucoma will progress. And so I think that's great for our patients. In the end, it's all about the patients. And the study does show that using angle surgery may be beneficial to your patients as well.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
© 2025 MJH Life Sciences

All rights reserved.